Announcements

Bunge Global SA filed a Form 8-K on September 21, 2026, disclosing that two of its wholly owned subsidiaries agreed with their lenders to extend the maturity dates on three unsecured revolving credit facilities, with changes taking effect in October 2026.

American Superconductor Corporation filed a Form 8-K on September 21, 2026, reporting that board member Barbara G. Littlefield resigned from the Board of Directors, effective September 18, 2026.

GT Biopharma, Inc. filed a current report on Form 8-K on September 21, 2026, disclosing a First Amendment to its Securities Purchase Agreement dated September 18, 2026, which added a new purchaser and increased the size of its previously announced private placement of Series …

Jack in the Box Inc. filed an 8-K with the SEC on September 21, 2026, disclosing a new independent director appointment, an upcoming board retirement, and an amendment to its cooperation agreement with GreenWood Investors, LLC.

CVRx, Inc. (NASDAQ:CVRX), a medical device company listed on the Nasdaq Global Select Market, filed a current report on September 21, 2026, disclosing the appointment of John Landry as Chief Financial Officer, effective following a transition period beginning October 12, 2026.

Travere Therapeutics, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on September 21, 2026, disclosing a planned CEO succession and the terms of a transition agreement with its departing chief executive.

The Toro Company filed a Form 8-K on September 21, 2026, disclosing the election of David W. Huml to its Board of Directors and two board committees, effective immediately.